| 注册
首页|期刊导航|中国伤残医学|替罗非班和阿司匹林与氯吡格雷联合血塞通注射液治疗超溶栓时间窗急性进展性脑梗死患者的效果分析

替罗非班和阿司匹林与氯吡格雷联合血塞通注射液治疗超溶栓时间窗急性进展性脑梗死患者的效果分析

刘永辉

中国伤残医学2024,Vol.32Issue(24):82-85,90,5.
中国伤残医学2024,Vol.32Issue(24):82-85,90,5.DOI:10.13214/j.cnki.cjotadm.2024.024.020

替罗非班和阿司匹林与氯吡格雷联合血塞通注射液治疗超溶栓时间窗急性进展性脑梗死患者的效果分析

Effect Analysis of Tirofiban and Aspirin and Clopidogrel Combined with Xuesaitong Injection in the Treatment of Acute Progressive Cerebral Infarction after Thrombolytic Time Window

刘永辉1

作者信息

  • 1. 山东省莒县中医医院急诊科,山东 日照 276800
  • 折叠

摘要

Abstract

Objective:To investigate the efficacy of Tirofiban and Clopidogrel and Aspirin in combined with Xuesaitong Injection the treatment of patients with acute progressive cerebral infarction(APCI)after thrombolytic time window.Methods:Data of 76 APCI patients after thrombolysis time window treated in Ju County Traditional Chinese Medicine Hospital from January 2022 to January 2024 were retrospectively analyzed.According to different treatment methods,they were divided into a control group and a study group,with 38 cases in each group.Both groups received conventional therapy.On this basis,the control group was treated with Tirofiban,Clopidogrel and Aspirin,and the study group was treated with was used Xuesaitong Injection on the basis of control group.Both groups were treated continuously for 14 days.The clinical efficacy,adverse reactions,coagulation function and nerve function of the two groups were compared.Results:The total effective rate of the study group was 94.74%,which was higher than 78.95%of the control group,the difference was statistically significant(P<0.05).After treatment,the National Institute of Health stroke scale of the study group was(13.11±1.01)points,which was lower than(19.34±1.32)points of the control group,and the difference was statistically significant(P<0.05).After treatment,the prothrombin time and activated partial thromboplastin time of the study group were(11.47±1.55)s and(27.11±2.68)s,respectively,which were longer than(10.74±1.36)s and(25.79±2.29)s of the control group,and the differences were statistically significant(P<0.05).The incidence of adverse reactions in the study group was 13.16%,compared with 7.89%in the control group,the difference was not statistically significant(P>0.05).Conclusion:For APCI patients after thrombolysis time window,Tirofiban,Clopidogrel and Aspirin combined with Xuesaitong Injection can show significant effects,which can not only optimize the coagulation function,accelerate the rehabilitation process of neurological function,but also have a high safety.

关键词

急性进展性脑梗死/替罗非班/氯吡格雷/阿司匹林/神经功能/血塞通注射液

Key words

Acute progressive cerebral infarction/Tilofiban/Clopidogrel/Aspirin/Neurological function/Xuesaitong Injection

分类

医药卫生

引用本文复制引用

刘永辉..替罗非班和阿司匹林与氯吡格雷联合血塞通注射液治疗超溶栓时间窗急性进展性脑梗死患者的效果分析[J].中国伤残医学,2024,32(24):82-85,90,5.

中国伤残医学

1673-6567

访问量0
|
下载量0
段落导航相关论文